Pune-based drug company Emcure Pharmaceuticals has acquired Canada’s International Pharmaceutical Generics Ltd. (IPG) and its marketing arm Marcan Pharmaceuticals, according to a report in The Economic Times.
These acquisitions will give the Indian pharmaceutical company an entry into the Canadian market.
Emcure, which recently estimated its annual global sales at over $670 million, makes a range of drugs such as Asomex, used to treat blood pressure. Cardiology, gynaecology and anti-infective medicines account for a bulk of its portfolio.
The company currently has nine manufacturing plants, including one in the US, and exports to a number of countries including the US, Europe, Brazil and Japan.
IPG is in the business of licensing, importing and distributing prescription pharmaceutical and over the counter finished formulations in Canada. Since the launch of its first product in 2007, the company has grown to offer over 40 products covering a range of therapeutic categories.